Terms: = Skin cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
12 results:
1. HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma.
Sriramareddy SN; Faião-Flores F; Emmons MF; Saha B; Chellappan S; Wyatt C; Smalley I; Licht JD; Durante MA; Harbour JW; Smalley KSM
Cancer Gene Ther; 2022 Dec; 29(12):1840-1846. PubMed ID: 35332245
[TBL] [Abstract] [Full Text] [Related]
2. Nuts and bolts of the salt-inducible kinases (SIKs).
Darling NJ; Cohen P
Biochem J; 2021 Apr; 478(7):1377-1397. PubMed ID: 33861845
[TBL] [Abstract] [Full Text] [Related]
3. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
Lobl MB; Clarey D; Higgins S; Sutton A; Hansen L; Wysong A
J Dermatol Sci; 2020 Jul; 99(1):30-43. PubMed ID: 32595073
[TBL] [Abstract] [Full Text] [Related]
4. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
Vashisht Gopal YN; Gammon S; Prasad R; Knighton B; Pisaneschi F; Roszik J; Feng N; Johnson S; Pramanik S; Sudderth J; Sui D; Hudgens C; Fischer GM; Deng W; Reuben A; Peng W; Wang J; McQuade JL; Tetzlaff MT; Di Francesco ME; Marszalek J; Piwnica-Worms D; DeBerardinis RJ; Davies MA
Clin Cancer Res; 2019 Nov; 25(21):6429-6442. PubMed ID: 31439581
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnosis and treatment for 46 cases of Peutz-Jeghers syndrome].
Jia Y; Fu H; Li N; Kang Q; Sheng J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 43(12):1323-1327. PubMed ID: 30643048
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma.
Afzal MZ; Mercado RR; Shirai K
J Immunother Cancer; 2018 Jul; 6(1):64. PubMed ID: 29966520
[TBL] [Abstract] [Full Text] [Related]
7. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Olvedy M; Tisserand JC; Luciani F; Boeckx B; Wouters J; Lopez S; Rambow F; Aibar S; Thienpont B; Barra J; Köhler C; Radaelli E; Tartare-Deckert S; Aerts S; Dubreuil P; van den Oord JJ; Lambrechts D; De Sepulveda P; Marine JC
J Clin Invest; 2017 Jun; 127(6):2310-2325. PubMed ID: 28463229
[TBL] [Abstract] [Full Text] [Related]
8. Mutational Analysis of BRAF Inhibitor-Associated Squamoproliferative Lesions.
Clynick B; Tabone T; Fuller K; Erber W; Meehan K; Millward M; Wood BA; Harvey NT
J Mol Diagn; 2015 Nov; 17(6):644-51. PubMed ID: 26319365
[TBL] [Abstract] [Full Text] [Related]
9. A mouse model uncovers lkb1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation.
Esteve-Puig R; Gil R; González-Sánchez E; Bech-Serra JJ; Grueso J; Hernández-Losa J; Moliné T; Canals F; Ferrer B; Cortés J; Bastian B; Ramón Y Cajal S; Martín-Caballero J; Flores JM; Vivancos A; García-Patos V; Recio JÁ
PLoS Genet; 2014 Oct; 10(10):e1004721. PubMed ID: 25329316
[TBL] [Abstract] [Full Text] [Related]
10. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
[TBL] [Abstract] [Full Text] [Related]
11. AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes.
Cao C; Lu S; Kivlin R; Wallin B; Card E; Bagdasarian A; Tamakloe T; Chu WM; Guan KL; Wan Y
J Biol Chem; 2008 Oct; 283(43):28897-908. PubMed ID: 18715874
[TBL] [Abstract] [Full Text] [Related]
12. In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.
Ikediobi ON; Reimers M; Durinck S; Blower PE; Futreal AP; Stratton MR; Weinstein JN
Mol Cancer Ther; 2008 Jun; 7(6):1337-46. PubMed ID: 18524847
[TBL] [Abstract] [Full Text] [Related]
